FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

871530006: Passive immunity stimulant therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3973199017 Passive immunity stimulant therapeutic role en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3973200019 Passive immunity stimulant therapeutic role (role) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Passive immunity stimulant therapeutic role est un(e) (attribut) Therapeutic role (role) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
SYNAGIS 100 milligrams per milliliter powder for solution for injection Boehringer Ingelheim (BI) Pharma KG (real clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
HBIg HepaGam B STR Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
HYPERTET S/D 250 units per dose solution for injection Grifols Canada Limited (real clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
IMOGAM 150 international units per milliliter solution for injection Sanofi Pasteur SA (real clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Diphtheria antitoxin (equine) 170 milligrams per milliliter solution for injection Institute of Immunology Inc. (real clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Diphtheria Antitoxin B.P. 1000 international units per milliliter solution for injection VINS Bioproducts Limited (real clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
VarIg VariZIG STR Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
RabIg KamRAB KAM Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
HyperHEP B S/D 220 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Cytogam 50 milligrams per milliliter solution for infusion CSL Behring AG (real clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
CMVIg Cytogam STR Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation (real clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
HYPERRAB S/D 150 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Medicinal product acting as passive immunity stimulant (product) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
VarIg varicella immunoglobulin unspecified Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Varicella-zoster virus antibody only product Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Varicella-zoster virus antibody 104 unit/mL solution for injection Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Varicella-zoster virus antibody-containing product in parenteral dose form Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Varicella-zoster virus antibody only product in parenteral dose form Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
poudre de 500 mg d'immunoglobuline contre le virus varicella-zoster pour solution injectable en flacon (médicament clinique) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
poudre de 250 mg d'immunoglobuline contre le virus varicella-zoster pour solution injectable en flacon (médicament clinique) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
médicament contenant palivizumab (produit médicinal) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Palivizumab only product Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Palivizumab only product in parenteral dose form Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Palivizumab 50 mg powder for solution for injection vial Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Palivizumab-containing product in parenteral dose form Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
TIg tetanus immunoglobulin unspecified Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing only human tetanus immunoglobulin (medicinal product) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing human tetanus immunoglobulin in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing only human tetanus immunoglobulin in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
HBIg hepatitis B immunoglobulin unspecified Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing only Hepatitis B surface antigen immunoglobulin (medicinal product) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Hepatitis B surface antigen immunoglobulin only product in parenteral dose form Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
RabIg rabies immunoglobulin unspecified Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing only rabies human immune globulin (medicinal product) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing rabies human immune globulin in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing precisely rabies human immune globulin 150 unit/1 milliliter conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Rabies human immune globulin only product in parenteral dose form Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing equine diphtheria antitoxin (medicinal product) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Equine diphtheria antitoxin-containing product in parenteral dose form Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Equine diphtheria antitoxin only product in parenteral dose form Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Equine diphtheria antitoxin only product Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Cytomegalovirus antibody-containing product in parenteral dose form Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Cytomegalovirus antibody only product in parenteral dose form Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing Cytomegalovirus antibody (medicinal product) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing only Cytomegalovirus antibody (medicinal product) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing precisely human tetanus immunoglobulin 250 international unit/1 milliliter conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing precisely palivizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing precisely Hepatitis B surface antigen immunoglobulin 500 unit/1 milliliter conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing precisely Hepatitis B surface antigen immunoglobulin 50 unit/1 milliliter conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing precisely human tetanus immunoglobulin 100 international unit/1 milliliter conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Product containing precisely rabies human immune globulin 300 international unit/1 milliliter conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
RIg HyperRAB Grif Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
Diphtheria Antitoxin (DAT) 1000 international units per milliliter solution for injection Instituto Butantan Brasil (real clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some
HyperTET 250 antitoxin units per milliliter solution for injection Grifols Canada Limited (real clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Some

Reference Sets

Canada English language reference set (foundation metadata concept)

Description inactivation indicator reference set

GB English

US English

Back to Start